Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 4 |
2024 | 1 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
The impact of the gut microbiome on tumor immunotherapy: from mechanism to application strategies.
Cell Biosci. 2023 Oct 13;13(1):188. doi: 10.1186/s13578-023-01135-y.
Cell Biosci. 2023.
PMID: 37828613
Free PMC article.
Review.
Hypoxia signaling in cancer: Implications for therapeutic interventions.
Zhuang Y, Liu K, He Q, Gu X, Jiang C, Wu J.
Zhuang Y, et al. Among authors: liu k.
MedComm (2020). 2023 Jan 23;4(1):e203. doi: 10.1002/mco2.203. eCollection 2023 Feb.
MedComm (2020). 2023.
PMID: 36703877
Free PMC article.
Review.
Item in Clipboard
MDFI promotes the proliferation and tolerance to chemotherapy of colorectal cancer cells by binding ITGB4/LAMB3 to activate the AKT signaling pathway.
Ma D, Liu S, Liu K, Kong L, Xiao L, Xin Q, Jiang C, Wu J.
Ma D, et al. Among authors: liu k.
Cancer Biol Ther. 2024 Dec 31;25(1):2314324. doi: 10.1080/15384047.2024.2314324. Epub 2024 Feb 20.
Cancer Biol Ther. 2024.
PMID: 38375821
Free PMC article.
Item in Clipboard
Ezetimibe inhibits triple-negative breast cancer proliferation and promotes cell cycle arrest by targeting the PDGFR/AKT pathway.
He Q, Kong L, Shi W, Ma D, Liu K, Yang S, Xin Q, Jiang C, Wu J.
He Q, et al. Among authors: liu k.
Heliyon. 2023 Oct 29;9(11):e21343. doi: 10.1016/j.heliyon.2023.e21343. eCollection 2023 Nov.
Heliyon. 2023.
PMID: 38027998
Free PMC article.
Item in Clipboard
A novel approach for the analysis of single-cell RNA sequencing identifies TMEM14B as a novel poor prognostic marker in hepatocellular carcinoma.
Ma D, Liu S, He Q, Kong L, Liu K, Xiao L, Xin Q, Bi Y, Wu J, Jiang C.
Ma D, et al. Among authors: liu k.
Sci Rep. 2023 Jun 28;13(1):10508. doi: 10.1038/s41598-023-36650-y.
Sci Rep. 2023.
PMID: 37380717
Free PMC article.
Item in Clipboard
Cite
Cite